Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients
Author:
Affiliation:
1. Hepatobiliary Surgery Department; Guangxi Medical University Cancer Hospital; Nanning China
2. Guangxi Medical University Cancer Hospital; Nanning China
Funder
the Graduate Course Construction Project of Guangxi Medical University
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15467/fullpdf
Reference10 articles.
1. Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis;Vilar-Gomez;Aliment Pharmacol Ther,2019
2. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study;Lai;Am J Gastroenterol,2012
3. Surveillance for hepatocellular carcinoma: current best practice and future direction;Kanwal;Gastroenterology,2019
4. Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study;Ruiter;Diabetes Care,2012
5. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals;Lee;BMC Cancer,2011
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients. Authors' reply;Alimentary Pharmacology & Therapeutics;2019-09-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3